The Online Resource for
the Pancreatic Cell Research Community
THIS WEEK'S TOP STORY
Human Umbilical Cord Perivascular Cells Improve Human Pancreatic Islet Transplant Function by Increasing Vascularization
The authors investigated the supportive effects of cotransplanting islets and perivascular mesenchymal stromal cells isolated from human umbilical cords (HUCPVCs). The HUCPVCs inhibited T cells and expressed proregenerative and immunoregulatory markers in vitro and increased islet vascularization in vivo. [Sci Transl Med]
Tweets by @PancreaticCell
Human Umbilical Cord Perivascular Cells Improve Human Pancreatic Islet Transplant...
Transcription Phenotypes of Pancreatic Cancer Are Driven by Genomic Events...
Volume 11.0 | Jan 07
ImmunoPET Predicts Response to Met-Targeted Radioligand Therapy in Models of...
Sign up today to save time and keep current by receiving free, weekly science newsletters delivered directly to your inbox!
"I really enjoy your newsletters and look forward to receiving them."
– Kathryn Futrega, B.Sc
Queensland University of Technology
"I often look forward to the weekly summaries from Connexon."
– Kristopher Lofgren, PhD
Boston Children's Hospital
"Great newsletter, especially like the weekly summary of articles in my field in my inbox so I don't have to go looking for them."
– Jennifer Adair, PhD, Fred Hutchinson Cancer Research Center and University of Washington
"I inadvertently got signed up for the newsletter. But because I found it so useful and informative, I have remained subscribed and actually recommended it to others."
– Gregory Weber, PhD
"Thank you so much for your email and your great newsletters. My team and I really enjoy them, and I cover your "MSC news" in our group meeting each Monday."
– Jan Nolta, PhD
Professor, UC Davis School of Medicine
"I have found these newsletters to be very valuable resources."
– Dean Yamaguchi, MD, PhD
Associate Chief of Staff
VA Greater Los Angeles Healthcare System
About Pancreatic Cell News
Pancreatic Cell News joined the Connexon Creative family of newsletters in the spring of 2010, providing scientists and medical professionals with weekly updates on pancreatic cancer, pancreatitis and diabetes research at the cellular level. We developed Pancreatic Cell News to support the communication of scientific and medical research, and to provide a platform for researchers to obtain high quality, up-to-date information about the pancreatic cell research field. By facilitating the communication of cutting edge scientific publications and news, we keep researchers current while saving them valuable time.
Pancreatic Cell News highlights the most recent top articles in the field of pancreatic research that have been carefully selected from high impact, peer reviewed academic and medical journals by our experienced editorial team. Specifically, the Pancreatitis and Diabetes Research section of Pancreatic Cell News features research articles discussing the diagnosis, progression and treatment of these diseases at the cellular level, including examinations of cell characteristics and explorations of potential pancreatic cell transplant therapies. Additionally, the Pancreatic Cancer section of the newsletter provides comprehensive coverage of the latest research findings in pancreatic cancer cell characterization, proliferation and regulation, as well as the progression, metastasis and treatment of the disease. The Industry and Science News sections of Pancreatic Cell News update readers on the latest press releases discussing new clinical trials, diagnostic tools and therapies, as well as award and funding opportunities from key research organizations and medical institutions. Lastly, the Jobs and Events sections keep readers current with career postings and conference announcements related to the field of pancreatic cell research, respectively.
With over 2,500 email subscribers, Pancreatic Cell News appeals to a diverse group of readers in the global scientific community, including science and medical students, academic researchers and medical professionals, and individuals from the pharmaceutical and biotech industries who focus on diseases of the pancreas, including pancreatic cancer, pancreatitis and diabetes research. In addition to sending weekly email newsletters, we stay engaged with the pancreatic research community through the @Pancreatic_Cell Twitter feed, which provides daily updates on science news of interest to the field. Finally, we encourage readers to submit pancreatic research articles and review papers, jobs, press releases and events for possible inclusion in an upcoming issue of Pancreatic Cell News.